Cited by

• Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.

  Firdaus R, Biswas A, Saha K, Mukherjee A, Chaudhuri S, Chandra A, Konar A, Sadhukhan PC. Firdaus R, et al. PLoS One. 2014 Jun 10;9(6):e99126. doi: 10.1371/journal.pone.0099126. eCollection 2014. PLoS One. 2014. PMID: 24914551 Free PMC article.
• New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.

  Quer J, Buti M, Cubero M, Guardia J, Esteban R, Esteban JI. Quer J, et al. Infect Drug Resist. 2010;3:133-45. doi: 10.2147/IDR.S7136. Epub 2010 Nov 23. Infect Drug Resist. 2010. PMID: 21694902 Free PMC article.
• IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort.

  Pár A, Pár G, Tornai I, Szalay F, Várszegi D, Fráter E, Papp M, Lengyel G, Fehér J, Varga M, Gervain J, Schuller J, Nemes Z, Péterfi Z, Tusnádi A, Hunyady B, Haragh A, Szinku Z, Vincze A, Szereday L, Kisfali P, Melegh B. Pár A, et al. BMC Res Notes. 2014 Jan 8;7:12. doi: 10.1186/1756-0500-7-12. BMC Res Notes. 2014. PMID: 24398031 Free PMC article.
• The Distribution of Genotype and Allelic Frequency of IL28B Gene Polymorphism in Andhra Pradesh, India.

  Sivaprasad S, Rao PN, Gupta R, Ashwini K, Reddy DN. Sivaprasad S, et al. J Clin Exp Hepatol. 2012 Jun;2(2):112-5. doi: 10.1016/S0973-6883(12)60098-X. Epub 2012 Jul 21. J Clin Exp Hepatol. 2012. PMID: 25755419 Free PMC article.
• Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.

  Keane C, O'Shea D, Reiberger T, Peck-Radosavljevic M, Farrell G, Bergin C, Gardiner CM. Keane C, et al. PLoS One. 2013 Jun 24;8(6):e66831. doi: 10.1371/journal.pone.0066831. Print 2013. PLoS One. 2013. PMID: 23826153 Free PMC article.